- Effects of Switching from Fenofibrate to Pemafibrate for Asymptomatic Primary Biliary Cholangitis
-
Dohmen K, Onohara Sy, Harada S
- KMID: 2521497
- Korean J Gastroenterol.
- 2021 Oct;78(4):227-234.
- doi: 10.4166/kjg.2021.092
Background/Aims: The addition of a fibrate to ursodeoxycholic acid (UDCA) is the standard treatment for asymptomatic primary biliary cholangitis (aPBC) with an incomplete response to UDCA. Among the fibrates, bezafibrate... -
- CITED
-
- Close
- SHARE
-
- Close
- Extended-spectrum beta-Lactamases: Implications for the Clinical Laboratory and Therapy
-
Harada S, Ishii Y, Yamaguchi
- KMID: 1781573
- Korean J Lab Med.
- 2008 Dec;28(6):401-412.
- doi: 10.3343/kjlm.2008.28.6.401
Production of extended-spectrum beta-lactamase (ESBL) is one of the most important resistance mechanisms that hamper the antimicrobial treatment of infections caused by Enterobacteriaceae. ESBLs are classified into several groups according... -
- CITED
-
- Close
- SHARE
-
- Close
